scholarly article | Q13442814 |
P50 | author | John K Amory | Q79189384 |
P2093 | author name string | Alvin M Matsumoto | |
Bradley D Anawalt | |||
William J Bremner | |||
Terry R Brown | |||
Barry R Zirkin | |||
Karen L Herbst | |||
Jonathan P Jarow | |||
Andrea D Coviello | |||
William W Wright | |||
Xiaohua Yan | |||
P2860 | cites work | Restoration of spermatogenesis by exogenously administered testosterone in rats made azoospermic by hypophysectomy or withdrawal of luteinizing hormone alone | Q28329433 |
Newer agents for hormonal contraception in the male | Q33838248 | ||
Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production | Q34024549 | ||
Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men. | Q34562139 | ||
Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. | Q34643925 | ||
Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. I. Circulating hormone levels | Q36432778 | ||
Follicle-stimulating hormone and human spermatogenesis | Q37004349 | ||
An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men. | Q42668582 | ||
Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development | Q43793797 | ||
Low dose of cyproterone acetate and testosterone enanthate for contraception in men. | Q47908290 | ||
Clomiphene Citrate: A Correlation of Its Effect on Sperm Concentration and Morphology, Total Gonadotropins, ICSH, Estrogen and Testosterone Excretion, and Testicular Cytology in Normal Men1 | Q49030268 | ||
Testosterone Concentrations in Testes of Normal Men: Effects of Testosterone Propionate Administration | Q53858583 | ||
P433 | issue | 6 | |
P921 | main subject | testosterone | Q1318776 |
testosterone | Q27863114 | ||
P304 | page(s) | 931-938 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Journal of Andrology | Q3177744 |
P1476 | title | Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen | |
P478 | volume | 25 |
Q56679619 | Advances in male contraception |
Q41875399 | An approach to constitutional delay of growth and puberty. |
Q55405743 | Binge Drinking and Intergenerational Implications: Parental Preconception Alcohol Impacts Offspring Development in Rats. |
Q23922004 | Cadmium concentrations in blood and seminal plasma: correlations with sperm number and motility in three male populations (infertility patients, artificial insemination donors, and unselected volunteers) |
Q64246674 | Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? |
Q53536012 | Central hypogonadism due to a giant, "silent" FSH-secreting, atypical pituitary adenoma: effects of adenoma dissection and short-term Leydig cell stimulation by luteinizing hormone (LH) and human chorionic gonadotropin (hCG). |
Q28083691 | Clinical management of infertile men with nonobstructive azoospermia |
Q90531292 | Continuing the search for a hormonal male contraceptive |
Q34032007 | Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency |
Q90025306 | Effects of pharmacologically induced Leydig cell testosterone production on intratesticular testosterone and spermatogenesis† |
Q27012485 | Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone |
Q40829905 | Male contraception: Where do we go from here? |
Q90182220 | Male contraception: where are we going and where have we been? |
Q49027395 | Male hormonal contraception: where do we stand? |
Q92723069 | Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery |
Q64250245 | Managing congenital hypogonadotrophic hypogonadism: a contemporary approach directed at optimizing fertility and long-term outcomes in males |
Q92625875 | Microdissection testicular sperm extraction: Overall results and impact of preoperative testosterone level on sperm retrieval rate in patients with nonobstructive azoospermia |
Q91649176 | New frontiers in fertility preservation: a hypothesis on fertility optimization in men with hypergonadotrophic hypogonadism |
Q38898947 | Novel concepts in male factor infertility: clinical and laboratory perspectives |
Q38727234 | Preserved seminiferous tubule integrity with spermatogonial survival and induction of Sertoli and Leydig cell maturation after long-term organotypic culture of prepubertal human testicular tissue |
Q91719580 | Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men |
Q37173461 | Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin |
Q33835802 | Serum LH correlates highly with intratesticular steroid levels in normal men |
Q36501771 | Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial |
Q24201286 | Steroid hormones for contraception in men |
Q24245039 | Steroid hormones for contraception in men |
Q38234051 | Steroid receptors and their ligands: effects on male gamete functions. |
Q37210366 | Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats |
Q56345463 | Testicular degeneration and infertility following arbovirus infection |
Q36530218 | Testicular fine-needle aspiration for the assessment of intratesticular hormone concentrations. |
Q38293550 | The pharmacotherapy of male hypogonadism besides androgens |
Q37718605 | Update on male hormonal contraception: is the vasectomy in jeopardy? |
Search more.